Join
today

Boliven PRO is more than just patent search

  • Build and save lists using the powerful Lists feature
  • Analyze and download your search results
  • Share patent search results with your clients

Patents »

US20090148400: COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE

Share

Filing Information

Inventor(s) Harpreet Singh · Steffen Walter · Toni Weinschenk · Norbert Hilf · Oliver Schoor · Claudia Lemmel ·
Assignee(s) Immatics Biotechnologies GmhH ·
Correspondent Baker Donelson Bearman, Caldwell & Berkowitz, PC ·
Application Number US12180113
Filing date 07/25/2008
Publication date 06/11/2009
Predicted expiration date 07/25/2028
U.S. Classifications 424/851  · 424/236.1  · 514/13  · 514/12  · 514/14  · 424/937  · 424/185.1  · 514/15  ·
International Classifications A61K3808  · A61K3810  · A61K3816  · A61K3817  · A61K3819  · A61K3900  · A61K39106  · A61P3500  ·
Kind CodeA1
Foreign Priority EP07014796.2 - 07/27/2007 ·
20 Claims, 7 Drawings


Abstract

The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer.

Independent Claims | See all claims (20)

  1. 1. A pharmaceutical composition comprising at least two peptides containing an amino acid sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 7, and a pharmaceutically acceptable carrier.

References Cited

The current document has no citations.

Referenced By

The current document is not referenced by other documents.

Patent Family

The current document is not in a family.